Shanghai, China

Yuyao Gu

This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Biomea Fusion, Inc.. Active years: 2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Yuyao Gu. Retrieved from https://idiyas.com/inventor/yuyao-gu

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 1 

% Patents Active = 100.0

Average Co-Inventor Count = 15.0

ph-index = 1


Company Filing History:


Years Active: 2025

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of Yuyao Gu

Introduction

Yuyao Gu is a notable inventor based in Shanghai, China. He has made significant contributions to the field of pharmaceuticals through his innovative work. His expertise and dedication have led to the development of unique compounds that hold promise for various applications.

Latest Patents

Yuyao Gu holds a patent for a compound described as N-[4-[4-(4-morpholinyl)-7H-pyrrolo[2,3-d]pyrimidin-6-yl]phenyl]-4-[[3(R)-[(1-oxo-2-propen-1-yl)amino]-1-piperidinyl]methyl]-2-pyridinecarboxamide. This compound, referred to as Compound A, showcases his innovative approach to drug development. He has 1 patent to his name, reflecting his commitment to advancing pharmaceutical science.

Career Highlights

Yuyao Gu is currently employed at Biomea Fusion, Inc., where he continues to push the boundaries of innovation in the pharmaceutical industry. His work is characterized by a focus on developing new therapeutic agents that can address unmet medical needs.

Collaborations

Throughout his career, Yuyao Gu has collaborated with talented professionals, including Satish Goud Puppali and James T Palmer. These collaborations have enriched his research and contributed to the success of his projects.

Conclusion

In summary, Yuyao Gu is a distinguished inventor whose work in pharmaceuticals has led to significant advancements. His innovative spirit and collaborative efforts continue to inspire progress in the field.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…